Patient Guide: A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 27 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05787587
Status: 🟢 Enrolling Now
Condition: Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, Colorectal Cancer, Head and Neck Cancers, Extensive Stage Small Cell Lung Cancer (ES-SCLC), NSCLC
Phase: PHASE1

Find a Study Location Near You

This study is available at 27 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Phoenix, Arizona
  • Los Angeles, California
  • Newport Beach, California
  • • And 24 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily